Provectus Biopharmaceuticals (PVCT) Preferred Shares (2010 - 2026)
Provectus Biopharmaceuticals (PVCT) reported Preferred Shares of $15,705 for Q2 2026, up 7.0% from $14,681 a year earlier.
Analysis
Provectus Biopharmaceuticals (PVCT) Preferred Shares (2010 - 2026) Analysis & Trends
At the end of FY2025, Provectus Biopharmaceuticals posted Preferred Shares of $15,140, up 7.7% from FY2024.
- Preferred Shares has a four-year compound annual growth rate of -8.5% (FY2021 to FY2025).
- By year, Preferred Shares came in at $14,063 in FY2024 (-38.1%), $22,734 in FY2023 (+2.8%), $22,120 in FY2022 (+2.4%) and $21,592 in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Preferred Shares since Q1 2024.
- Year over year, Preferred Shares gained in four of the last seven quarters, with an average decline of 11.2%.
- The high point for year-over-year Preferred Shares in five years was Q2 2025 (growth of 13.3%); the low point was Q2 2024 (a decline of 42.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | - |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | - |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | - |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | - |
| 10 | Provectus Biopharmaceuticals | 21.01 Mn | 19.10 Mn | - | 15,705.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 15,705.00 |
| Dec 31, 2025 | 15,140.00 |
| Sep 30, 2025 | 14,932.00 |
| Jun 30, 2025 | 14,681.00 |
| Mar 31, 2025 | 14,428.00 |
| Dec 31, 2024 | 14,063.00 |
| Sep 30, 2024 | 13,969.00 |
| Jun 30, 2024 | 12,960.00 |
| Mar 31, 2024 | 22,960.00 |
| Dec 31, 2023 | 22,734.00 |
| Sep 30, 2023 | 22,519.00 |
| Jun 30, 2023 | 22,327.00 |
| Mar 31, 2023 | 22,138.00 |
| Dec 31, 2022 | 22,120.00 |
| Sep 30, 2022 | 21,644.00 |
| Jun 30, 2022 | 21,644.00 |
| Mar 31, 2022 | 21,644.00 |
| Dec 31, 2021 | 21,592.00 |
| Sep 30, 2021 | 21,592.00 |
| Jun 30, 2021 | 21,814.00 |
API Access
Provectus Biopharmaceuticals Preferred Shares API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=preferred-shares&ticker=PVCT&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "preferred-shares", "ticker": "PVCT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=preferred-shares&ticker=PVCT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();